OCC and NSB have both recently had giant rerates with corresponding market hype based on trial results for similar conditions that AMT are already treating successfully with equally novel regenerative & reconstructive, proprietary medical technologies.
OCC and NSB have both recently had giant rerates with...
Add to My Watchlist
What is My Watchlist?